Endologix Inc. Announces US Launch Of The VELA™ Proximal Endograft System

Published: Feb 10, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the United States launch of its new VELA™ Proximal Endograft System. The VELA Proximal Endograft is specifically designed for the treatment of proximal aortic neck anatomies during an endovascular aneurysm repair ('EVAR') procedure using the Endologix AFX® Endovascular AAA System. The proximal neck is the portion of the aorta that is above the aneurysm and below the renal arteries.

Help employers find you! Check out all the jobs and post your resume.

Back to news